When Was Lorcaserin Launched?

Lorcaserin (BELVIQ) is a US-approved weight loss agent. Lorcaserin (10mg tablet twice daily) was approved in 2012 and a slow release preparation (BELVIQ XR, 20 mg once daily) was approved in July and launched in October 2016.

How much weight can you lose with lorcaserin?

Lorcaserin, used in combination with diet and exercise, results in modest weight loss of about 12.9 lb (5.8 kg) compared with 5.6 lb (2.5 kg) with placebo.

When was lorcaserin taken off the market?

Eisai Inc. withdrew Belviq (lorcaserin) from the U.S. market in February 2020 at the request of the U.S. Food and Drug Administration. The FDA requested the withdrawal after it reviewed Belviq safety data and found an increased occurrence of cancer in people who took the drug.